Dan Hirschovits
Lawyers
Filters
Gyroscope Therapeutics $148.0 million Series C equity financing
We advised Gyroscope Therapeutics on its private placement of preferred stock
Gates Industrial $379.5 million secondary offering
We advised the underwriters on the SEC-registered equity offering
Tronox $401 million secondary offering
We advised the underwriters on the equity offering
Anglo Pacific £46 million placing and retail offer of new shares
We advised the joint bookrunners on the transaction
NKT DKK 1.3 billion rights offering
Davis Polk advised NKT A/S in connection with its rights offering relating to 10,744,009 new shares. The offering consisted of a public offering in Denmark and a private placement to…
Ocado Group acquisition of Haddington Dynamics
Davis Polk is advising Ocado Group plc on its acquisition of Haddington Dynamics, a robotics-arm designer and manufacturer. Subject to satisfaction of certain closing conditions, the…
Ocado Group acquisition of Kindred Systems
Davis Polk is advising Ocado Group plc on its acquisition of Kindred Systems, an advanced piece-picking robotics company, for approximately $262 million in cash, subject to typical purchase…
Emirate of Abu Dhabi $5 billion notes offering
Davis Polk advised the joint lead managers in connection with a Rule 144A/Regulation S offering by the Emirate of Abu Dhabi of $2 billion aggregate principal amount of 0.750% notes due 2023…
Royalty Pharma $6 billion senior notes offering
Davis Polk advised Royalty Pharma plc in connection with its Rule 144A/Regulation S offering of $1 billion aggregate principal amount of its 0.75% senior notes due 2023, $1 billion…
Hashemite Kingdom of Jordan $1.75 billion notes offering
Davis Polk advised the joint lead managers in connection with the Rule 144A/Regulation S offering by the Hashemite Kingdom of Jordan of $500 million aggregate principal amount of its 4.950%…